Ranbaxy Pharmaceuticals
May 28, 2012 at 11:26 | Source: Moneycontrol.com
May 17, 2012 at 10:12 | Source: Reuters
May 15, 2012 at 15:05 | Source: Moneycontrol.com
May 11, 2012 at 14:31 | Source: Moneycontrol.com
May 10, 2012 at 18:30 | Source: CNBC-TV18
May 10, 2012 at 15:36 | Source: Moneycontrol.com
News across the web »
May 21, 2012 at 07:21 | Source: Economic Times
Apr 02, 2012 at 17:55 | Source: FirstPost
Apr 02, 2012 at 11:11 | Source: FirstPost
Apr 02, 2012 at 10:36 | Source: FirstPost
Mar 31, 2012 at 17:48 | Source: India Infoline
Interact & exchange stock tips & market info »
Drug firm Ranbaxy Laboratories today launched a generic version of Cad...
1.04 PM Dec 7th 2011
Related News »
Under the agreement with Ranbaxy, Cipher is responsible for product supply and manufacturing. About Cipher Pharmaceuticals Inc. Cipher Pharmaceuticals (TSX: DND; OTC: CPHMF.PK) is a growing specialty pharmaceutical company that commercializes ...
May 28, 2012 at 03:28 | Source: Yahoo Finance
Besides Pfizer, Ranbaxy and Watson Pharmaceuticals are allowed to sell generic Lipitor in the US till May 31. Managing director and chief executive officer Arun Sawhney said, “The focus on key products and markets, while maintaining emphasis on further ...
May 9, 2012 at 19:29 | Source: Business Standard
Other than the innovator Pfizer, Ranbaxy and Watson Pharmaceuticals are the only two drugmakers allowed to sell generic Lipitor in the United States until May 31. Efforts to improve effectiveness and efficiency are expected to further improve ...
May 9, 2012 at 09:49 | Source: Reuters
In August 2008, Cipher Pharma granted Ranbaxy Pharmaceuticals Inc. exclusive right to market, sell and distribute CIP-Isotretinoin in the United States, its territories and possessions. Following the FDA acceptance of the amended NDA as a complete response ...
May 14, 2012 at 07:55 | Source: RTT News
Janssen Pharmaceuticals Inc., sued Germany-based Haupt Pharma AG's U.S. unit, Haupt Pharma Inc., as well as India-based Ranbaxy Laboratories Ltd. and its New Jersey-based unit, Ranbaxy Laboratories Inc. Janssen alleges the generics makers filed abbreviated ...
May 23, 2012 at 17:10 | Source: site.law360.com
Ranbaxy Laboratories, Wockhardt, Biocon & GlaxoSmithKline Pharmaceuticals etc moved up by 1.5-6%. WATCHES sector will also be getting strong astrological support. Accumulate Titan Industries on decline. LEATHER sector will also continue receiving astrological support.
May 17, 2012 at 23:58 | Source: MoneyControl.com
But the patent has expired, and since November 30, 2011 there have been generics available from Watson Pharmaceuticals (WPI) and Ranbaxy Laboratories, with more certainly to come. Sales of Lipitor peaked at 12.8 billion in 2008. Sales were still over $10 ...
May 11, 2012 at 16:06 | Source: Seekingalpha.com
RANBAXY) and Sun Pharmaceuticals Industries Ltd (NSE: SUNPHARMA) while key gainers were Jaiprakash Associates Ltd (NSE: JPASSOCIAT), Bajaj Auto Ltd (NSE: BAJAJ-AUTO) and Tata Motors Ltd (NSE: TATAMOTORS). On sectoral front almost all the ...
May 11, 2012 at 11:19 | Source: Commodity Online
U.S. patent protection on the drug ended on Nov. 30. Watson Pharmaceuticals Inc. makes the authorized generic version in the U.S., and India's Ranbaxy Laboratories Ltd. is selling the only other approved version of the drug. Mylan and other ...
May 27, 2012 at 10:25 | Source: Yahoo Finance